# Extension Study of Protocol EV-BR1701 Group B1

> **NCT07630493** · — · COMPLETED · sponsor: **Enimmune Corporation** · enrollment: 126 (actual)

## Conditions studied

- Enterovirus Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07630493
- **Lead sponsor:** Enimmune Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-28
- **Primary completion:** 2025-01-05
- **Final completion:** 2025-09-09
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2026-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07630493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07630493, "Extension Study of Protocol EV-BR1701 Group B1". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07630493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*